Aspira Pathlab & Diagnostics Share Price

BSE
ASPIRA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Aspira Pathlab & Diagnostics Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
34.97% Fall from 52W High
13.4
Dividend yield 1yr %
0

Aspira Pathlab & Diagnostics shareholding Pattern

Promoter
18.6%
Public
81.5%
Promoter
18.6%
Public
81.5%
Promoter
18.7%
Public
81.3%
Promoter
18.7%
Public
81.3%
Promoter
18.9%
Public
81.1%
Promoter
18.9%
Public
81.1%

Aspira Pathlab & Diagnostics Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
13
5Day EMA
76.70
10Day EMA
81.50
12Day EMA
82.20
20Day EMA
82.60
26Day EMA
81.90
50Day EMA
78.40
100Day EMA
71.30
200Day EMA
60.80
5Day SMA
77.10
10Day SMA
86.80
20Day SMA
85.90
30Day SMA
80.90
50Day SMA
77.30
100Day SMA
72.90
150Day SMA
62.90
200Day SMA
54.90
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
3103 Rs
3103 Rs
Week Rs
1306 Rs
1306 Rs
Month Rs
4086 Rs
4086 Rs
Resistance & Support
70.17
Pivot
Resistance
First Resistance
70.90
Second Resistance
72.36
Third Resistance
73.09
Support
First Support
68.71
Second support
67.98
Third Support
66.52
Relative Strength Index
34.54
Money Flow Index
64.76
MACD
0.33
MACD Signal
3.36
Average True Range
4.10
Average Directional Index
39.02
Rate of Change (21)
-8.15
Rate of Change (125)
72.44

Aspira Pathlab & Diagnostics Company background

Founded in: 1973
Managing director: Pankaj Jashwant Shah
Aspira Pathlab Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with PanIndia presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services.Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year, the Company commenced its business activities of diagnostic center pathology from November 2016 onwards by acquiring running business activities of Ankur Pathology Laboratory. Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.
Read More

Aspira Pathlab & Diagnostics FAQs

You can easily buy Aspira Pathlab & Diagnostics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Aspira Pathlab & Diagnostics stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -